A new standard of care for patients with surgically unresectable stage III non-small cell lung cancer

被引：1

作者：

Gill, Harpaul S. ^{[1
]}

Ramalingam, Suresh S. ^{[1
]}

机构：

[1] Emory Univ, Sch Med, Dept Hematol & Oncol, Winship Canc Inst, 1365 Clifton Rd NE,Bldg C,Suite 4014, Atlanta, GA 30322 USA

来源：

CANCER | 2019年 / 125卷 / 13期

关键词：

durvalumab; immune checkpoint inhibition; NSCLC; PACIFIC trial; stage III NSCLC; RANDOMIZED PHASE-III; RADIATION-THERAPY; CONCURRENT CHEMORADIOTHERAPY; SEQUENTIAL CHEMORADIOTHERAPY; CONSOLIDATION DOCETAXEL; THORACIC RADIOTHERAPY; TRIAL; CHEMOTHERAPY; COMBINATION; CARBOPLATIN;

D O I：

10.1002/cncr.31996

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Overall survival data from the PACIFIC trial have reaffirmed earlier US Food and Drug Administration approval of durvalumab in patients with stage III non-small cell lung cancer. In the current commentary, the authors provide a brief historical perspective on stage III disease as well as a further analysis of the strengths and weaknesses of the trial.

引用

页码：2148 / 2153

页数：6

共 50 条

[31] Consolidation osimertinib for unresectable stage III epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer: redefining standard care
Wu, Fang
Zeng, Yue
Neal, Joel W.
TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (10) : 2853 - 2855
[32] Phase I study of concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer
Cardenal, Felipe
Arnaiz, Maria Dolores
Moran, Teresa
Jove, Josep
Nadal, Ernest
Porta, Ruth
Sole, Josep Maria
Brao, Isabel
Palmero, Ramon
Fuentes, Rafael
Nunez, Inmaculada
Caveda, Elena
Cassinello, Alejo
LUNG CANCER, 2011, 74 (01) : 69 - 74
[33] Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non-Small Cell Lung Cancer
Thatcher, Nicholas
Heighway, Jim
ONCOLOGIST, 2010, 15 (10): : 1034 - 1042
[34] Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer
Chu Chia-Hsun
Chiu Tzu-Hsuan
Wang Chin-Chou
Chang Wen-Chen
Huang Allen Chung-Cheng
Liu Chien-Ying
Wang Chih-Liang
Ko Ho-Wen
Chung Fu-Tsai
Hsu Ping-Chih
Guo Yi-Ke
Kuo, Chih-Hsi S.
Yang Cheng-Ta
THORACIC CANCER, 2020, 11 (06) : 1541 - 1549
[35] Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer
Gerald SMA Kerner
Leon FA van Dullemen
Erwin M Wiegman
Joachim Widder
Edwin Blokzijl
Ellen M Driever
John WG van Putten
Jeroen JW Liesker
Tineke EJ Renkema
Remge M Pieterman
Marc JF Mertens
Thijo JN Hiltermann
Harry JM Groen
Radiation Oncology, 9
[36] Real-World Insights into the Impact of Durvalumab on Stage III Unresectable Non-Small Cell Lung Cancer-A Narrative Review
Facheris, Giorgio
Cossali, Gianluca
Imbrescia, Jessica
La Mattina, Salvatore
Mataj, Eneida
Meli, Nicole
Volpi, Giulia
Triggiani, Luca
Guerini, Andrea Emanuele
Levi, Guido
Grisanti, Salvatore
di Monale e Bastia, Michela Buglione
Borghetti, Paolo
CANCERS, 2025, 17 (05)
[37] Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer
Harada, Hideyuki
Yamamoto, Nobuyuki
Takahashi, Toshiaki
Endo, Masahiro
Murakami, Haruyasu
Tsuya, Asuka
Nakamura, Yukiko
Ono, Akira
Igawa, Satoshi
Shukuya, Takehito
Tamiya, Akihiro
Nishimura, Tetsuo
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (06) : 507 - 512
[38] Single-center comparison of multiple chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small-cell lung cancer
Tabchi, Samer
Blais, Normand
Campeau, Marie-Pierre
Tehfe, Mustapha
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (02) : 381 - 387
[39] Chemoradiation for stage III non-small cell lung cancer
Ramella, Sara
Fiore, Michele
Iurato, Aurelia
Trodella, Luca E.
Trodella, Lucio
D'Angelillo, Rolando M.
EUROPEAN JOURNAL OF ONCOLOGY, 2013, 18 (01): : 5 - 13
[40] Immunotherapy for Unresectable Stage III Non-Small-Cell Lung Cancer
Rizvi, Naiyer A.
Peters, Solange
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1986 - 1988

← 1 2 3 4 5 →